When used in combination with certain chemotherapies, curcumin has been shown to increase apoptosis in several cancer cell lines. Here, we report the combined effects of curcumin and cinobufacini on human cervical carcinoma cells. The aim of this study was to examine whether curcumin could enhance apoptosis induced by cinobufacini. 3-(4,5-Dimethylthiazol-2-y1)-2,5-diphenytetrazolium bromide (MTT) assays revealed that the growth and proliferation of HeLa cells could be inhibited by 75% after a combined treatment of 25 μg/mL cinobufacini and 8 μg/mL curcumin. The combined treatment is 3 times more effective than treatment with 25 μg/mL cinobufacini alone. Annexin V-FITC/PI staining, morphological changes and immunofluorescence verified a significant enhancement in cinobufacini-induced apoptosis when cells were also exposed to curcumin. The data showed that the proportion of early apoptotic cells significantly increased from 15.43% in cells treated only with 25 μg/mL cinobufacini to 49.2% in cells treated with 25 μg/mL cinobufacini and 8 μg/mL curcumin. Moreover, compared with treatment of only 25 μg/mL cinobufacini, ROS production increased 1.7-fold, the intracellular free Ca 2+ concentration increased 1.5-fold, and the mitochondrial membrane potential decreased by 20% in the combined treatment. Simultaneously, the atomic force microscopy (AFM) results suggest that cells treated with a combination of cinobufacini and curcumin varied significantly in shape and ultrastructure. Collapsed cells with leaking cytoplasm, blebbing pores and emerging apoptotic bodies were prevalent. The nanoparticle size increased from 70 nm when the cells were treated with 25 μg/mL cinobufacini to 190 nm when the cells were treated with 25 μg/mL cinobufacini and 8 μg/mL curcumin. The size increase resulted in the cell membrane becoming considerably rough. These results can improve our understanding of combination treatments. Specifically, the combination of cinobufacini and curcumin may potentially find use as a novel cervical carcinoma treatment. Additionally, AFM is a powerful tool that can be used to explore cellular morphologies and ultrastructures. In this study, we combined cinobufacini (CIN) and curcumin (CUR) to treat cervical carcinoma. Recently, several traditional Chinese medicines with anti-tumor properties have attracted considerable interest as candidates for novel cancer therapeutics [7] . CIN is a watersoluble extract prepared from the skins of Bufo bufo gargarizans. Recent clinical studies have suggested that CIN,
used alone or in combination with other chemotherapeutic agents, has a profound effect on a number of cancers, particularly gastrointestinal tract carcinomas such as liver, pancreatic [8] , and gastric cancers [9, 10] .
CUR is a low molecular weight and natural polyphenolic compound isolated from the turmeric rhizome (Curcuma longa). CUR has been reported to harbor anti-oxidative, anti-inflammatory, anti-angiogenic, anti-proliferative, antitumor and wound healing properties [11] [12] [13] [14] [15] . CUR induces cancer cell apoptosis and shows low cytotoxicity in normal cells [16, 17] .
However, there are no reports on the combined effects of CIN and CUR on cervical cancer cells. The aim of this study was to examine whether CUR enhances CIN-induced apoptosis. We first used HeLa cervical cancer cell lines as a model to investigate CUR enhanced CIN-induced apoptosis. Simultaneously, an 3-(4,5-dimethylthiazol-2-y1)-2,5-diphenytetrazolium bromide (MTT) assay, immunofluorescence, and flow cytometry were used to analyze the underlying molecular mechanisms of this enhancement. In recent years, attempts to understand the cellular, subcellular and molecular mechanical changes that occur throughout human disease states, including cancer, have garnered significant scientific interest. The plasma membrane, which is the boundary between a living cell and its environment, plays a very important role in cellular physiology. The plasma membrane protects the cell [18] and regulates cellular functions, including the transport of nutrients [19, 20] . Understanding the relationships between cellular ultrastructures, cellular and cytoskeletal mechanical properties, biological function and human health and disease states is a research area that has garnered much attention [21] . In this paper, we used AFM to visualize nanoscale changes in the subcellular ultrastructure resulting from chemical treatment.
Materials and methods

Reagents and cell culture
CIN was obtained from Anhui Jinchan Biochemical Co. Ltd. (Huaibei, China). CUR was purchased from Tianjin Yongda Chemical Reagent Development Center (Tianjin, China). CUR was initially dissolved in dimethyl sulfoxide (DMSO) to obtain the desired concentrations. Fetal bovine serum, RPMI-1640, trypsin, and MTT kit was obtained from Gibco (New York, USA). An Annexin V-FITC/PI apoptosis detection kit, a Rhodamin 123 kit, a Fluo-3 AM kit, a 2′,7′-dichlorofluorescein diacetate kit, a 5,5′,6,6′-tetrachloro-1,1′, 3,3′-tetraethyl-imidacarbocyanine iodide (JC-1) kit, a 2-(4-amidinophenyl)-6-indo-119 lecarb-amidine dihydrochloride (DAPI) kit, and fluorescein isothiocyanate (FITC)-phalloidin were purchased from Beyotime, China. All reagents used in the experiments were analytical grade. The ultrapure water used for all experiments was supplied by the cascade RO water purification system from Pall (New York, USA).
The HeLa cells were purchased from the Life Science Research Institute of the Cell Resource Center in Shanghai, China. The cells were cultured in RPMI-1640 media supplemented with 2 mmol/L glutamine, 10% fetal bovine serum, 100 U/mL penicillin and 100 g/mL of streptomycin, and the cultures were grown at 37°C in a humidified atmosphere containing 5% CO 2 . When the cells grew to 70%-80% confluence, they were passed according to a 1:3 split. Once in the logarithmic growth phase, the cells were ready for the following experiments.
MTT assay
An MTT assay was employed to assess the toxicity effects of CIN alone or in combination with CUR on HeLa cells. Briefly, cells (6 ×10 4 cells/mL) were plated in 96-well plates. After 24 h, the cells were incubated with different concentrations of CIN (0, 6.25, 12.5, 25, 37.5 and 50 μg/mL) and either 4 μg/mL of CUR (CUR 4 ) or 8 μg/mL of CUR (CUR 8 ). The combined assay employed either 25 μg/mL CIN and 4 μg/mL CUR (CIN 25 /CUR 4 ) or 25 μg/mL CIN and 8 μg/mL CUR (CIN 25 /CUR 8 ); the cells were incubated with the agents for 48 h. Then, MTT was added to a final concentration of 10 μg/mL in each well for a 4-h incubation at 37°C. The medium was then removed, and the cells were suspended in 150 μL of DMSO for 15 min. A spectrophotometer (TECAN, Switzer-210 land) was used to measure the absorbances at a wavelength of 570 nm. The cell inhibitory rate was calculated using the following equation: Cell inhibitory rate = 1−(OD treatment −OD blank )/(OD control −OD blank )× 100%. Each experiment was repeated at least three times.
Determination of the apoptotic rate
Apoptosis was quantified using an Annexin V-FITC apoptosis kit, which detects the surface exposure of phosphatidylserine in cells. Briefly, cells were seeded in 6-well plates at a density of 2×10 5 cells/mL and incubated for 24 h. Then, the cells were either treated with CIN only at doses of 0, 6.25, 12.5, 25, or 37.5 μg/mL for 48 h or with CIN and CUR (CUR 4 or CUR 8 ) for 48 h. The cells were harvested, washed with ice-cold phosphate buffer saline (PBS), resuspended in 300 μL of binding buffer, and incubated with 5 μL of FITC-labeled Annexin V and 5 μL of PI for 15 min at room temperature in the dark. Then, the samples were immediately analyzed using a flow cytometer (BD Inc, New York, USA) at an excitation wavelength of 488 nm.
Measurement of changes in the cytoskeleton and nucleus
DAPI and FITC-phalloidin stains were used to observe the apoptotic cellular morphology and cytoskeletal rearrangements. Briefly, cells at a concentration of 3×10 5 cells/mL were seeded in six-well plates and incubated for 24 h. Af-terwards, the cells were treated with CIN 25 or with a combination of CIN 25 and CUR (CUR 4 or CUR 8 ) for 24 h. Then, the cells were fixed with 4% paraformaldehyde and stained successively with 50 μmol/L of DAPI for 5 min and 1 μmol/L of FITC-phalloidin for 60 min in the dark at room temperature. Finally, the cells were washed with PBS. A laser scanning confocal microscope (Carl Zeiss, Germany) was used to image the nuclear morphology and the organization of the F-actin cytoskeleton. The amounts of F-actin in HeLa cells that were untreated, treated solely with CIN 25 , or treated with a combination of CIN 25 and CUR were determined by flow cytometry and actin-tracker green. Briefly, the cells, after being washed and harvested, were fixed by treatment with 4% paraformaldehyde for 15 min. The cells were incubated with actin-tracker green for 30 min, washed three times with PBS, and then suspended in PBS. The samples were immediately excited at 496 nm and analyzed with a flow cytometer (BD Inc, New York, USA).
Atomic force microscopy
Atomic force microscopy (AFM) was used to obtain topographic images of untreated cells, cells treated with CIN 25 , and with cells treated with a combination of CIN 25 and CUR. Prior to use, the silicon nitride tips used in all AFM measurements were irradiated with ultraviolet light to remove organic contaminants. The curvature radius of the tips was less than 10 nm, the elasticity coefficient was set at 2.8 N/m, and the oscillation frequency was set at 255 kHz. The samples were fixed by treatment with a 4% paraformaldehyde solution for 15 min after being monolayer-cultured, washed twice and dried at room temperature. Single-cell imaging experiments were performed on more than five cells, and each cell was scanned three times.
Measurement of reactive oxygen species production
Levels of intracellular reactive oxygen species (ROS) were determined by a Reactive Oxygen Species Assay Kit, which uses the staining probe DCFH-DA. DCFH-DA is a nonfluorescent probe that can freely penetrate the cell membrane. In cells, DCFH is deacetylated by esterases to form 2′,7′-dichlorofluorescin (DCFH), a non-fluorescent molecule that reacts in the presence of ROS to form the fluorescent product 2′,7′-dichlorofluorescein (DCF). Briefly, cells were treated with CIN 25 or with CIN 25 in the presence of CUR (CUR 4 or CUR 8 ) for 24 h. The cells were then harvested, washed once with ice-cold PBS, and incubated with 10 μmol/L of DCFH-DA at 37°C for 30 min. After incubation with the fluorochrome, the cell culture was washed and resuspended in cold PBS. Then, to calculate the production of ROS, the fluorescence intensity was measured using flow cytometry; the flow cytometer was set at an excitation wavelength of 488 nm and an emission wavelength of 525 nm.
Detection of the intracellular free Ca
2+ concentration
The fluorescent dye Fluo-3 AM can cross the cell membrane and be converted into Fluo-3, which specifically reacts with Ca 2+ to produce a molecule that strongly fluoresces. To detect changes in the free calcium level within the cytosol, both CIN-treated and untreated HeLa cells were incubated with Fluo-3 AM. The detailed procedure is as follows: HeLa cells that were untreated, treated with CIN 25 for 24 h, or treated with CIN 25 in the presence of CUR (CUR 4 or CUR 8 ) for 24 h were collected, washed twice in PBS, and resuspended in Fluo-3 AM (5 μmol/L) for 30 min in the dark. The intracellular Ca 2+ concentration was measured using a flow cytometer set at an excitation wavelength of 488 nm.
Mitochondrial membrane potential measurement
The MMP was monitored separately using two fluorescent dyes, rhodamin 123 and JC-1. The cells were harvested, washed, and resuspended in Rhodamine 123 (2 μmol/L) for 30 min in the dark after being either treated with CIN 25 for 24 h or a combination of CIN 25 and CUR for 24 hours. The fluorescence was measured by flow cytometry at an excitation wavelength of 485 nm.
In the normal cell, JC-1 accumulates and aggregates in the matrix of the mitochondria, forming J-aggregates and fluorescing bright red. In apoptotic cells, however, JC-1 cannot aggregate in the matrix of the mitochondria due to the reduction of the MMP. Instead, JC-1 remains in the cytoplasm in its monomeric form and fluoresces green. The cells were seeded in confocal petri dishes after a 24-h treatment with CIN 25 or a 24-h treatment with CIN 25 in combination with CUR (CUR 4 or CUR 8 ). Then, 200 μL of JC-1 staining solution was added. The cells were incubated in this solution for 15 min. Then, the cells were washed with PBS and visualized directly under a laser scanning confocal microscope set to an excitation wavelength of 514 nm.
Results
The cytotoxic effect of CIN alone and in combination with CUR
To determine the ability of CUR to enhance the CINinduced growth suppression of cells, cells were treated either with CIN alone or with CIN and CUR. CUR significantly enhances CIN-induced cell cytotoxicity when the cells are incubated for 48 h at 37°C. The results shown in Figure 1 (a) revealed that after treatment for 48 h, CIN alone exhibited dose-dependent inhibitory effects on the viability of HeLa cells, and the inhibitory rate increased from 11% to 56%. We adopted a CIN concentration of 25 g/mL for the following combined experiments. The CIN 25 /CUR 4 combination treatment showed a growth inhibition rate of 64%, which is 2.5 times higher than that of CIN 25 alone. The CIN 25 /CUR 8 combination treatment showed a growth inhibition rate of 75%, which is 3 times higher than that of CIN 25 alone (Figure 1(b) ). These data suggested that the CIN-induced growth suppression of HeLa cells could be strengthened in the presence of CUR.
Apoptosis of HeLa cells induced by CIN alone and in combination with CUR
Annexin V-FITC/PI staining was carried out to assess the extent and mode of HeLa cell death. The kit measures phosphatidylserine turnover from the inner to the outer lipid layer of the plasma membrane, an event typically associated with apoptosis. The proportions of early apoptotic cells were 8.05%, 10.62%, 15.43%, and 18.24% after HeLa cells were treated with CIN at concentrations of 6.25, 12.5, 25, 37.5 and 50 μg/mL, respectively (Figure 2(a)-(c) ). Furthermore, Figure 2 
Derangement of the cytoskeleton and damage to the nucleus
Changes to cellular morphology were examined by specific staining after treatment with CIN alone or in combination with CUR. Specifically, the F-actin cytoskeleton was stained with Rhodamine-labeled phalloidin, and the nucleus was stained with DAPI. The cells were examined using a laser scanning confocal microscope (LSCM). Previous reports provided evidence that cytoskeletal alterations could induce apoptosis as well as necrosis in a variety of models [22] [23] [24] [25] [26] . Thus, it was very important to investigate whether the combined treatment affected the arrangement of the cytoskeleton. In Figure 3(a) and (b) , stains of control cells showed a generally homogeneous distribution of F-actin in the cytoplasm and intact, plump and uniform nuclei. After the 24-h treatment with CIN 25 , the F-actin aggregated and formed dot-like structures, and the nuclei presented as hippocrepiform. Furthermore, the cytoskeletal networks completely disappeared. When treated with the CIN 25 /CUR 8 combination, the cells presented the typical morphology of apoptotic cells: The nuclei had broken, the chromatin was condensed and gathered at the periphery of the nuclear membrane, and the edges of the cells became blurred. Additionally, the cells appeared more widely distributed on the substrate. These observations indicate that the combination treatment significantly inhibited the proliferation of HeLa cells by changing the organization of the F-actin cytoskeleton and breaking the nucleus. Actin-tracker green was also employed to measure the amount of F-actin before and after treatment with CIN 25 only or treatment with CIN 25 and CUR (CUR 4 or CUR 8 ). Figure 3(c) shows that the fluorescent signal of the actin tracker in HeLa cells decreased more in the combined treatment than in the treatment with CIN 25 alone. The MFI of cells treated with CIN 25 alone was 14670, while the MFI of cells treated with the CIN 25 /CUR 8 combination decreased to 9339. Taken together, these results revealed that the combined treatment was able to alter the organization of the cytoskeleton architecture by disrupting F-actin distribution and decreasing the expression of F-actin in HeLa cells more easily than the treatment with CIN 25 alone.
Cell morphology and cell membrane ultrastructure characterization
As a nondestructive cell surface imaging tool, AFM was used to observe a variety of changes in the surface morphology and membrane ultrastructure of HeLa cells treated with CIN in the presence and absence of CUR [27] . As shown in Figure 4 , the control cells had a regular, long spindle-shaped morphology, and the nuclei were plump and elliptical. The cell tails were unrolled, and the cell surface was relatively smooth and intact (Figure 4(a) and (e)). After treatment with CIN 25 alone, the cells shrunk, but the nuclei remained intact (Figure 2 Moreover, AFM can provide nanoscale insight into ultrastructural changes occurring in the topography of the cell membrane [28] . Figure 5 shows the cell surface ultrastructure of HeLa cells treated with CIN alone or in combination with CUR. The cell membrane architecture of the control cells ( Figure 5 (a) ) was homogeneous and presented a granular morphology with a surface particle size of approximately 45 nm. After CIN 25 treatment alone, the surface of the cells became rough, and the nanoparticle size increased to 70 nm; the form became scattered. The visibly protruding particles are clusters of membrane proteins [29] . Furthermore, the cytoskeletal structure of the control cells presented regular networks of F-actin, while the cytoskeleton networks disappeared and presented a gathered state after the combined treatments (shown in Figure 3 ). The nanoparticles on the cell membrane were aggregated and not a uniform size. The size increased to 150 and 190 nm for the CIN 25 / CUR 4 and CIN 25 /CUR 8 combinations, respectively ( Figure   5 (c) and (d)). Taken together, these morphological data revealed dose-dependent morphological changes corresponding to the combined treatment. The combined treatment mainly induced cell apoptosis. The morphological changes implied that some physiological changes could occur in membrane proteins, including the opening and closing of ion channels, the disruption of the ion channel structure, and alterations to the chemical composition of the outer membrane [30] . The altered chemical composition of the outer membrane may have led to changes in the ultrastructure of the cytoskeleton and membrane surface. Further, these results provide morphological information about the combined effects of induced HeLa cell toxicity (damage). The combined treatments affected the external structure of HeLa cells. This result might be related to F-actin disorganization, mitochondria-dependent apoptosis, or disruption of the nucleus.
Mitochondria-dependent apoptosis induced by enhancement of ROS overproduction and the free Ca 2+ level
Previous studies have shown that ROS, by-products of aerobic metabolism, play vital roles in intracellular signaling cascades [31, 32] . Mitochondria are one of the major sources of intracellular ROS, and overproduction of ROS can trigger stress pathways that ultimately lead to cell apoptosis [33] . High ROS levels can also cause cellular damage, depending on the duration of ROS stress [34] , and ROS can function as anti-tumor agents [35] . A novel cancer therapy strategy preferentially eradicates cancer cells by targeting the ROS stress-response pathway [36] . Thus, we investigated changes in ROS production in cells before and after being treated with CIN or CIN in combination with CUR. Figure 6 (a) and (b) show the data collected by the flow )). We have demonstrated that the combination treatment triggers oxidative stress and that oxidative stress plays a major role in inducing apoptotic changes in HeLa cells.
Increased intracellular Ca 2+ concentration is also recognized as an important marker of cell death and injury [37] . Thus, we measured the intensity of fluo-3 fluorescence, an indicator of the Ca 2+ concentration. Figure 6( 2+ concentration was related to HeLa cell apoptosis. Cell signaling can be activated by a temporary increase in the cytoplasmic calcium level as a result of a calcium channel opening in the plasma membrane or the endoplasmic reticulum [38] . The rise in the cytoplasmic Ca 2+ concentration resulting from the combined treatment might be largely associated with membrane collapse ( Figure 4 ). Membrane collapse could promote the opening of Ca 2+ channels in the cell membrane and the subsequent influx of Ca 2+ .
MMP loss induced by enhancement of ROS overproduction
The loss of MMP could lead to cytochrome c release [39, 40] , a decrease in adenosine triphosphate (ATP) generation [41] , the activation of caspases and initiation of apoptotic cascades [42] , all of which play important roles in the induction of cell death (necrosis or apoptosis). JC-1 staining was used to qualitatively confirm MMP disruption [43] . Rhodamine 123 was used to quantitatively detect the loss of MMP [44] . The JC-1 stain provides a distinct visual result, as red fluorescence is the indicator of higher MMP levels, while green fluorescence is the indicator of lower MMP levels. The combined treatment induced a dose-dependent fluorescent shift from red to green, indicating that the combined treatment disrupted MMP in HeLa cells (Figure 7(a) ). Moreover, the fluorescent intensity of Rhodamine 123 was reduced more by the combined treatment than by treatment with CIN 25 alone. Figure 7 
Discussion
In this study, we first assessed the combined effects of CUR and CIN on human cervical carcinoma cells. The data show that inhibition of viability and induction of apoptosis are more significant for the combined treatment than for treatment with CIN alone. Moreover, the disorganization and depolymerization of the F-actin skeleton and the damage to the nucleus show that combination treatments induce apoptosis. The intracellular oxidative stress resulting from the accumulation of ROS plays a key role in inducing apoptosis [45, 46] . The increase of intracellular ROS by CIN is considered to be a major mechanism in CIN-induced cell injury and the principal CIN treatment in cancer therapy [47] . ROS lead to free radical attack of membrane phospholipids and the loss of MMP, which releases inter-membrane proteins (such as cytochrome c) from the mitochondria. This process leads to the opening of a mitochondrial permeability transition pore and Ca 2+ efflux from the cytoplasm [48, 49] . In the presence of CUR, the increased ROS level suggests that the combined treatment triggers the generation of oxidative stress. CUR could be a suitable chemical sensitizer of CIN-induced apoptosis. The MMP governs the electrochemical forces employed for ATP synthesis and other metabolic activities, including the maintenance of Ca 2+ homeostasis within the mitochondria [50] . Due to the energy requirements of the different Ca 2+ transport systems that control Ca 2+ homestasis, the loss of MMP and the subsequent ATP depletion invariably result in the disruption of intracellular Ca 2+ homeostasis. These results demonstrate that the CUR enhancement of CIN-induced apoptosis in HeLa cells operates via ROS-dependent pathways. In this process, the ROS level and cytosolic free Ca 2+ concentration increase, and the MMP decreases more significantly than after CIN treatment alone.
Changes to the membrane structure have a direct influence on cellular function [51, 52] . AFM morphological data indicate that the cell surface morphology changed from homogeneous to heterogenous. The AFM morphological data indicated shrinkage, blebbing, and the appearance of pores on the membrane. Furthermore, the ultrastructure of control cells presented regular networks of F-actin (shown in Figure 3 ), The cytoskeleton networks disappeared and presented a gathered state after the combined treatment (CIN 25 /CUR 8 ) (Figure 3 ). CIN 25 -induced cells had a particle size of 70 nm. The particle size on the cell surface increased to 150 nm for CIN 25 /CUR 4 and to 190 nm for CIN 25 /CUR 8 ( Figure 5 ). This result suggested the altered chemical composition of the outer membrane or a reduction in the number of microvilli upon combined treatment with CIN and CUR.
Furthermore, AFM enabled the detection of subtle (nanoscale) changes to the structure of the cancer cell upon treatment with CIN 25 alone or in combination with CUR. These results provided insight into the structure-function relationship of cell surfaces and yielded a more comprehensive understanding of the drug-cell interactions during chemotherapy. These treatments disrupted the MMP and subsequently induced apoptosis. Moreover, these treatments were reflected in the ultrastructure of the cell surface.
Conclusion
This research provided detailed insights into potentially novel cervical carcinoma treatments. Moreover, this study demonstrated CUR's enhancement of CIN-induced apoptosis. The results from this study could provide visual diagnoses to early stage apoptosis in tumor cells in response to anti-cancer drugs. These studies also yield insight into drugcell interactions. However, more research will be required to fully understand the specific anti-cancer mechanism of the enhancement of CIN-induced apoptosis by CUR. 
